Annual Total Expenses
$52.00 M
+$16.87 M+48.01%
December 31, 2023
Summary
- As of February 8, 2025, ATNM annual total expenses is $52.00 million, with the most recent change of +$16.87 million (+48.01%) on December 31, 2023.
- During the last 3 years, ATNM annual total expenses has risen by +$29.61 million (+132.22%).
- ATNM annual total expenses is now at all-time high.
Performance
ATNM Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Expenses
$12.60 M
+$183.00 K+1.47%
September 30, 2024
Summary
- As of February 8, 2025, ATNM quarterly total expenses is $12.60 million, with the most recent change of +$183.00 thousand (+1.47%) on September 30, 2024.
- Over the past year, ATNM quarterly total expenses has increased by +$2.18 million (+20.88%).
- ATNM quarterly total expenses is now -19.44% below its all-time high of $15.64 million, reached on June 30, 2023.
Performance
ATNM Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
ATNM Total Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +48.0% | +20.9% |
| 3 y3 years | +132.2% | +88.0% |
| 5 y5 years | +118.2% | +89.4% |
ATNM Total Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +99.2% | -19.4% | +106.4% |
| 5 y | 5-year | at high | +135.6% | -19.4% | +171.9% |
| alltime | all time | at high | >+9999.0% | -19.4% | >+9999.0% |
Actinium Pharmaceuticals Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $12.60 M(+1.5%) |
| Jun 2024 | - | $12.42 M(+29.4%) |
| Mar 2024 | - | $9.60 M(-7.9%) |
| Dec 2023 | $52.00 M(+48.0%) | $10.42 M(-27.4%) |
| Sep 2023 | - | $14.35 M(-8.3%) |
| Jun 2023 | - | $15.64 M(+35.0%) |
| Mar 2023 | - | $11.58 M(+2.6%) |
| Dec 2022 | $35.13 M(+34.6%) | $11.29 M(+14.7%) |
| Sep 2022 | - | $9.84 M(+24.7%) |
| Jun 2022 | - | $7.89 M(+29.3%) |
| Mar 2022 | - | $6.10 M(-24.4%) |
| Dec 2021 | $26.11 M(+16.6%) | $8.07 M(+20.4%) |
| Sep 2021 | - | $6.70 M(+25.5%) |
| Jun 2021 | - | $5.34 M(-10.9%) |
| Mar 2021 | - | $5.99 M(-6.9%) |
| Dec 2020 | $22.39 M(+1.5%) | $6.43 M(+14.6%) |
| Sep 2020 | - | $5.61 M(+20.4%) |
| Jun 2020 | - | $4.66 M(-18.0%) |
| Mar 2020 | - | $5.68 M(+22.6%) |
| Dec 2019 | $22.07 M(-7.4%) | $4.63 M(-30.3%) |
| Sep 2019 | - | $6.65 M(+30.8%) |
| Jun 2019 | - | $5.09 M(-10.8%) |
| Mar 2019 | - | $5.70 M(-10.4%) |
| Dec 2018 | $23.83 M(-11.5%) | $6.36 M(+2.7%) |
| Sep 2018 | - | $6.20 M(+26.1%) |
| Jun 2018 | - | $4.91 M(-22.7%) |
| Mar 2018 | - | $6.35 M(+22.0%) |
| Dec 2017 | $26.91 M(+0.2%) | $5.21 M(-22.2%) |
| Sep 2017 | - | $6.70 M(-7.1%) |
| Jun 2017 | - | $7.20 M(-7.7%) |
| Mar 2017 | - | $7.81 M(+14.3%) |
| Dec 2016 | $26.85 M(+8.1%) | $6.83 M(-3.9%) |
| Sep 2016 | - | $7.10 M(+2.6%) |
| Jun 2016 | - | $6.92 M(+15.3%) |
| Mar 2016 | - | $6.00 M(+22.0%) |
| Dec 2015 | $24.83 M | $4.92 M(+6.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2015 | - | $4.64 M(-37.3%) |
| Jun 2015 | - | $7.40 M(-5.9%) |
| Mar 2015 | - | $7.87 M(+14.4%) |
| Dec 2014 | $22.48 M(+241.2%) | $6.87 M(-2.4%) |
| Sep 2014 | - | $7.04 M(+59.2%) |
| Jun 2014 | - | $4.42 M(+6.9%) |
| Mar 2014 | - | $4.14 M(+178.8%) |
| Dec 2013 | $6.59 M(-17.1%) | $1.48 M(-7.8%) |
| Sep 2013 | - | $1.61 M(+9.0%) |
| Jun 2013 | - | $1.48 M(-26.9%) |
| Mar 2013 | - | $2.02 M(-45.5%) |
| Dec 2012 | $7.95 M(+142.0%) | $3.70 M(+54.3%) |
| Sep 2012 | - | $2.40 M(+185.9%) |
| Jun 2012 | - | $839.30 K(-16.5%) |
| Mar 2012 | - | $1.01 M(-69.3%) |
| Dec 2011 | $3.28 M(>+9900.0%) | $3.28 M(>+9900.0%) |
| Sep 2011 | - | $2400.00(-33.3%) |
| Jun 2011 | - | $3600.00(+44.0%) |
| Mar 2011 | - | $2500.00(-63.2%) |
| Dec 2010 | $25.40 K(+75.2%) | $6800.00(-16.0%) |
| Sep 2010 | - | $8100.00(+102.5%) |
| Jun 2010 | - | $4000.00(-38.5%) |
| Mar 2010 | - | $6500.00(+1.6%) |
| Dec 2009 | $14.50 K(-22.9%) | $6400.00(+190.9%) |
| Sep 2009 | - | $2200.00(+4.8%) |
| Jun 2009 | - | $2100.00(-46.2%) |
| Mar 2009 | - | $3900.00(-400.0%) |
| Dec 2008 | $18.80 K(-12.6%) | -$1300.00(-161.9%) |
| Sep 2008 | - | $2100.00(-74.7%) |
| Jun 2008 | - | $8300.00(-14.4%) |
| Mar 2008 | - | $9700.00(-30.7%) |
| Dec 2007 | $21.50 K(+22.9%) | $14.00 K(+197.9%) |
| Sep 2007 | - | $4700.00(+67.9%) |
| Jun 2007 | - | $2800.00(>+9900.0%) |
| Mar 2007 | - | $0.00(-100.0%) |
| Dec 2006 | $17.50 K | $7500.00(-25.0%) |
| Sep 2006 | - | $10.00 K |
FAQ
- What is Actinium Pharmaceuticals annual total expenses?
- What is the all time high annual total expenses for Actinium Pharmaceuticals?
- What is Actinium Pharmaceuticals annual total expenses year-on-year change?
- What is Actinium Pharmaceuticals quarterly total expenses?
- What is the all time high quarterly total expenses for Actinium Pharmaceuticals?
- What is Actinium Pharmaceuticals quarterly total expenses year-on-year change?
What is Actinium Pharmaceuticals annual total expenses?
The current annual total expenses of ATNM is $52.00 M
What is the all time high annual total expenses for Actinium Pharmaceuticals?
Actinium Pharmaceuticals all-time high annual total expenses is $52.00 M
What is Actinium Pharmaceuticals annual total expenses year-on-year change?
Over the past year, ATNM annual total expenses has changed by +$16.87 M (+48.01%)
What is Actinium Pharmaceuticals quarterly total expenses?
The current quarterly total expenses of ATNM is $12.60 M
What is the all time high quarterly total expenses for Actinium Pharmaceuticals?
Actinium Pharmaceuticals all-time high quarterly total expenses is $15.64 M
What is Actinium Pharmaceuticals quarterly total expenses year-on-year change?
Over the past year, ATNM quarterly total expenses has changed by +$2.18 M (+20.88%)